본문 바로가기
KERD
논문KCI 등재

MicroRNAs in Human Diseases: From Lung, Liver and Kidney Diseases to Infectious Disease, Sickle Cell Disease and Endometrium Disease

하대유
대한면역학회 (The Korean Association of Immunologists)|2011.12|Immune Network|제11권 제6호|pp. 309-323

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

LiverKidneyInfectious diseasesLungMicroRNAsSickle cell disease

초록

MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs of about 22 nucleotides that have recently emerged as important regulators of gene expression at the posttranscriptional level. Recent studies provided clear evidence that microRNAs are abundant in the lung, liver and kidney and modulate a diverse spectrum of their functions. Moreover, a large number of studies have reported links between alterations of miRNA homeostasis and pathological conditions such as infectious diseases, sickle cell disease and endometrium diseases as well as lung, liver and kidney diseases. As a consequence of extensive participation of miRNAs in normal functions, alteration and/or abnormalities in miRNAs should have importance in human diseases. Beside their important roles in patterning and development,miRNAs also orchestrated responses to pathogen infections. Particularly, emerging evidence indicates that viruses use their own miRNAs to manipulate both cellular and viral gene expression. Furthermore, viral infection can exert a profound impact on the host cellular miRNA expression profile, and several RNA viruses have been reported to interact directly with cellular miRNAs and/or to use these miRNAs to augment their replication potential. Here I briefly summarize the newly discovered roles of miRNAs in various human diseases including infectious diseases, sickle cell disease and enodmetrium diseases as well as lung, liver and kidney diseases.

Abstract

MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs of about 22 nucleotides that have recently emerged as important regulators of gene expression at the posttranscriptional level. Recent studies provided clear evidence that microRNAs are abundant in the lung, liver and kidney and modulate a diverse spectrum of their functions. Moreover, a large number of studies have reported links between alterations of miRNA homeostasis and pathological conditions such as infectious diseases, sickle cell disease and endometrium diseases as well as lung, liver and kidney diseases. As a consequence of extensive participation of miRNAs in normal functions, alteration and/or abnormalities in miRNAs should have importance in human diseases. Beside their important roles in patterning and development,miRNAs also orchestrated responses to pathogen infections. Particularly, emerging evidence indicates that viruses use their own miRNAs to manipulate both cellular and viral gene expression. Furthermore, viral infection can exert a profound impact on the host cellular miRNA expression profile, and several RNA viruses have been reported to interact directly with cellular miRNAs and/or to use these miRNAs to augment their replication potential. Here I briefly summarize the newly discovered roles of miRNAs in various human diseases including infectious diseases, sickle cell disease and enodmetrium diseases as well as lung, liver and kidney diseases.

참고문헌 (100)

  1. Tili E, "Expression and function of micro-RNAs in immune cells during normal or disease state", Int J Med Sci, 5, pp.73~79 (2008)
  2. Slaby O, "MicroRNAs in colorectal cancer: translation of molecular biology into clinical application", Mol Cancer, 8, pp.102~ (2009)
  3. Small EM, "Pervasive roles of microRNAs in cardiovascular biology", Nature, 469, pp.336~342 (2011)
  4. 하대유, "MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease", Immune Network, 11(3), pp.135~154 (2011), 대한면역학회
  5. 하대유, "MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases", Immune Network, 11(5), pp.227~244 (2011), 대한면역학회
  6. 하대유, "The Role of MicroRNAs in Regulatory T Cells and in the Immune Response", Immune Network, 11(1), pp.11~41 (2011), 대한면역학회
  7. O'Connell RM, "Physiological and pathological roles for microRNAs in the immune system", Nat Rev Immunol, 10, pp.111~122 (2010)
  8. Wang GK, "Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans", Eur Heart J, 31, pp.659~666 (2010)
  9. Miller BH, "MicroRNA dysregulation in psychiatric disease", Brain Res, 1338, pp.89~99 (2010)
  10. Belver L, "MicroRNAs prevent the generation of autoreactive antibodies", Immunity, 33, pp.713~722 (2010)
  11. Guo H, "Mammalian microRNAs predominantly act to decrease target mRNA levels", Nature, 466, pp.835~840 (2010)
  12. Perera JR, "MicroRNAs in the search for understanding human diseases", Biodrug, 21, pp.97~104 (2007)
  13. Dai R, "MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases", Transl Res, 157, pp.163~179 (2011)
  14. Lu M, "An analysis of human microRNA and disease associations", PLoS One, 3, pp.e3420~ (2008)
  15. Tomankova T, "Involvement of microRNAs in physiological and pathological process in the lung", Resp Res, 11, pp.159~169 (2010)
  16. van Pottelberge G, "MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary diseases", Am J Respir Crit Care Med, 183, pp.898~906 (2011)
  17. Caramori G, "Mechanisms involved in lung cancer develop ment in COPD", Int J Biochem Cell Biol, 43, pp.1030~1044 (2011)
  18. Jopling CI, "Modulation of hepatitis C virus RNA abundance by a liver- specific microRNA", Science, 309, pp.1577~1581 (2005)
  19. Chen XM, "MicroRNA signatures in liver diseases", World J Gastroenterol, 15, pp.1665~1672 (2009)
  20. Trang P, "MicroRNAs as potential cancer therapeutics", Oncogene, 27, pp.S52~S57 (2009)
  21. Li LM, "Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes", J Immunol, 186, pp.2552~2560 (2011)
  22. Lu LF, "MicroRNA in the immune system, microRNA as an immune system", Immunology, 127, pp.291~298 (2009)
  23. Li Y, "MicroRNA expression and virulence in pandemic influenza virus-infected mice", J Virol, 84, pp.3023~3032 (2010)
  24. Cullen BR, "Viruses and microRNAs", Nat Genet, 38, pp.S25~S30 (2006)
  25. Pallante P, "Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas", Endocrine-Related Cancer, 17, pp.F91~F104 (2010)
  26. Calin GA, "MicroRNA signatures in human cancers", Nature Rev Cancer, 6, pp.857~866 (2006)
  27. Shenouda SK, "MicroRNA function in cancer: oncogene or a tumor suppressor", Cancer Metasis Rev, 28, pp.369~378 (2009)
  28. Bartel DP, "MicroRNAs: Genomics, biogenesis, mechanisms, and funtion", Cell, 116, pp.281~297 (2004)
  29. Kim VN, "Biogenesis of small RNAs in animals", Nature Rev Mol Cell Biol, 10, pp.126~139 (2009)
  30. V. Narry Kim, "Small RNAs: Classification, Biogenesis, and Function", Molecules and Cells, 19(1), pp.1~15 (2005), 한국분자세포생물학회
  31. Boyd SD, "Everything you wanted to know about small RNA but were afraid to ask", Lab Invest, 88, pp.569~578 (2008)
  32. Rodriquez A, "Identification of mammalian microRNA host genes and transcription units", Genome Res, 14, pp.1902~1910 (2004)
  33. Sonkoly E, "Advances in microRNAs: implications for immunity and inflammatory diseases", J Cell Mol Med, 13, pp.24~38 (2009)
  34. Hunsberger JG, "MicroRNAs in mental health: from biological underpinnings to potential therapies", Neuromol Med, 11, pp.173~182 (2009)
  35. Sato T, "Reduced miR-146a increases prostaglandin E2 in chronic obstructive pulmonary disease fibroblast", Am J Repir Crit Care Med, 182, pp.1020~1029 (2010)
  36. Schembri F, "MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium", Proc Natl Acad Sci U S A, 106, pp.2319~2324 (2009)
  37. Pandit KV, "Inhibition and role of let-7d in idiopathic pulmonary fibrosis", Am J Respir Crit Care Med, 182, pp.220~229 (2010)
  38. Liu G, "miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis", J Exp Med, 204, pp.1589~1597 (2010)
  39. Coward WR, "The pathogenesis of idiopathic pulmonary fibrosis", Ther Adv Respir Dis, 4, pp.367~388 (2010)
  40. Oglesby IK, "miR-126 is downregulated in cystic fibrosis airway epitherlial cells and regualtes TOM1 expression", J Immunol, 184, pp.1702~1709 (2010)
  41. Miranda RC, "MicroRNAs: Master regulators of ethanol abuse and toxicity", Alcohol Clin Exp Res, 34, pp.1~13 (2010)
  42. Tang Y, "Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease", Alcohol Clin Exp Res, 32, pp.355~364 (2008)
  43. Otto EA, "NEK8 mutations affect ciliary and centrosomal localization and may cause nepronophthisis", J Am Soc Nephrol, 19, pp.587~592 (2008)
  44. Pandey P, "Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease", BMC Genomics, 9, pp.624~ (2008)
  45. Sarnow P, "MicroRNAs: expression, avoidance and subversion by vertebrate viruses", Nat Rev Microbiol, 4, pp.651~659 (2006)
  46. Xiao B, "Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response", J Infect Dis, 200, pp.916~925 (2009)
  47. Gupta A, "Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript", Nature, 442, pp.82~85 (2006)
  48. Stern-Ginossary N, "Host immune system gene targeting by a viral miRNA", Science, 317, pp.376~381 (2007)
  49. Song L, "Cellular microRNAS inhibit replication of the H1N1 influenza A virus in infected cells", J Virol, 84, pp.8849~8860 (2010)
  50. Guo W, "Candidate Mycobacterium tuberculosis genes targeted by human microRNAs", Protein Cell, 1, pp.419~421 (2010)
  51. Liu Z, "Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis", Molec Immunol, 48, pp.1084~1090 (2011)
  52. De Flora S, "The prevention of infection-associated cancers", Carinogenesis, 32, pp.787~795 (2011)
  53. Schulte LN, "Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family", The EMBOJ, 30, pp.1977~1989 (2011)
  54. Tili E, "Modulation of miR-155 and miR-125b levels following lipopolysaccharide", TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock, 2007, pp.179, 5082~5089
  55. Orkin SH, "Sickle cell disease at 100 years", Science, 329, pp.291~292 (2010)
  56. Chen SY, "The genomic analysis of erythrocyte microRNA expression in sickle cell disease", PLoS ONE, 3, pp.e2360~ (2008)
  57. Sankaran VG, "MicroRNA- 15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13", Proc Natl Acad Sci, 108, pp.1519~1524 (2011)
  58. Pan Q, "MicroRNA signature and regulatory functions in the endometrium during normal and disease states", Semin Reprod Med, 26, pp.479~493 (2008)
  59. Germain RN, "Systems biology in immunology: A computational modeling perspective", Ann Rev Immunol, 29, pp.527~585 (2011)
  60. Izzotti A, "Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke", FASEB J, 23, pp.806~812 (2009)
  61. Liu X, "Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus- infected human hepatoma cells", Virology, 398, pp.57~67 (2010)
  62. Kota J, "Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model", Cell, 137, pp.1005~1017 (2009)
  63. Bala S, "Emerging role of microRNAs in liver diseases", World Gastroenterol, 15, pp.5633~5640 (2009)
  64. Hildebrandt F, "Nephronophthisis-associated ciliopathies", J Am Soc Nephrol, 18, pp.1855~1871 (2007)
  65. Witwer KW, "MicroRNA regulation of IFN-β protein expression: Rapid and sensitive modulation of the innate immune response", J Immunol, 184, pp.2369~2376 (2010)
  66. Belair C, "Helicobacter pylori and gastric cancer: possible role of microRNA in this intimate relationship", Clin Microbiol Infect, 15, pp.806~812 (2009)
  67. Zhang GL, "Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210", Antiviral Res, 88, pp.169~173 (2010)
  68. Ura S, "Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma", Hepatol, 49, pp.1098~1112 (2009)
  69. Pedersen IM, "Interferon modulation of cellular microRNs as an antiviral mechanism", Nature, 18, pp.919~922 (2007)
  70. Ohlsson Teague EM, "MicroRNA-regulated pathways associated with endometriosis", Mol Endocrinol, 23, pp.275~275 (2009)
  71. Davidson MR, "MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma", PLoS ONE, 5, pp.e12560~ (2010)
  72. Cho JH, "Systems biology of interstitial lung diseases: integration of microRNA expression", BMC Med Genom, 4, pp.8~ (2011)
  73. Pandit KV, "MicroRNAs in idiopathic pulmonary fibrosis", Transl Res, 157, pp.191~199 (2011)
  74. Bouros D, "Acute interstitial pneumonia", Eur Respir J, 15, pp.412~418 (2000)
  75. Berkhout B, "RISCy business: MicroRNAs, pathogenesis, and viruses", J Biol Chem, 282, pp.26641~26645 (2007)
  76. Lecellier CH, "A cellular microRNA mediates antiviral defense in human cells", Science, 308, pp.557~560 (2005)
  77. Ghosh Z, "Cellular versus viral microRNAS in host-virus interaction", Nucl Acids Res, 37, pp.1035~1048 (2009)
  78. Jin WB, "HBV-encoded microRNA candidate and its target", Comput Biol, 31, pp.124~126 (2007)
  79. Lee SO, "MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease", J Clin Invest, 118, pp.3714~3724 (2008)
  80. Chu AS, "A role for microRNA in cystic liver and kidney diseases", J Clin Invest, 118, pp.3585~3587 (2008)
  81. Wang K, "Circulating microRNAs, potential biomarker for drug-induced liver injury", Proc Natl Acad Sci, 106, pp.4402~4407 (2009)
  82. Dolganiuc A, "MicroRNA expression profile in Lieber-DeCarlie diet induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice", Alcohol Clin Exp Res, 33, pp.1704~1710 (2009)
  83. Skalsky RL, "Viruses, microRNAs, and host interactions", Annu Rev Microbiol, 64, pp.123~141 (2010)
  84. Grundhoff A, "Virus-encoded microRNAs", Virology, 411, pp.325~343 (2011)
  85. Grassmann R, "The roles of microRNAs in mammalian virus infection", Biochim Biophys Acta, 1779, pp.706~711 (2008)
  86. Gottwein E, "Viral and cellular microRNAs as determinants of viral pathogenesis and immunity", Cell Host Microbs, 3, pp.375~387 (2008)
  87. Sonkoly E, "MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation", Semin Cancer Biol, 18, pp.131~140 (2008)
  88. Pfeffer S, "Identification of virus-encoded microRNAs", Science, 304, pp.734~736 (2004)
  89. Pfeffer S, "Identification of microRNAs of the herpesvirus family", Nat Methods, 2, pp.269~276 (2005)
  90. Sullivan CS, "SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells", Nature, 435, pp.682~686 (2005)
  91. Lodish HF, "Micromanagement of the immune system by microRNAs", Nat Rev Immunol, 8, pp.120~130 (2008)
  92. DiChiara JM, "Multiple small RNAs identified in Mycobacerium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis", Nucleic Acid Res, 38, pp.4067~4078 (2010)
  93. Zhang B, "microRNAs: new emerging class of players for disease diagnosis and gene", J Cell Mol Med, 12, pp.3~21 (2008)
  94. Gottwein E, "A viral microRNA functions as an ortholog of cellular miR-155", Nature, 450, pp.1096~1099 (2007)
  95. Huang J, "Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes", Nature Med, 13, pp.1241~1247 (2007)
  96. Potenza N, "Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen", Nucleic Acids Res, 39, pp.5157~5163 (2011)
  97. Saba R, "A miRNA signature of prion induced neurodegeneration", PLoS ONE, 3, pp.e3652~ (2008)
  98. Fassi Fehri L, "Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner", PLoS One, 5, pp.e9500~ (2010)
  99. Matsushima K, "MicroRNA signature in Helicobacter pylori-infected gastric mucosa", Int J Cancer, 128, pp.361~370 (2011)
  100. Voinnet O, "Micro-balancing innate immunity to Salmonella", The EMBO J, 30, pp.1877~1879 (2011)

관련 논문AI추천

MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease하대유대한면역학회 · Immune Network2011 · 제11권 제3호MiR-146 and miR-125 in the regulation of innate immunity and inflammation김태성, 이혜미, 조은경생화학분자생물학회 · BMB Reports2016 · 제49권 제6호microRNA biomarkers in cystic diseases박종훈, 우유미생화학분자생물학회 · BMB Reports2013 · 제46권 제7호MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative Diseases하대유대한면역학회 · Immune Network2011 · 제11권 제5호MicroRNA in the Diseased Pulmonary Vasculature: Implications for the Basic Scientist and Clinician민필기, Richard C. Jin, MD, Stephen Y. Chan, MD대한고혈압학회 · Clinical Hypertension2013 · 제19권 제1호MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology김종민생화학분자생물학회 · BMB Reports2018 · 제51권 제2호

이 간행물의 다른 논문 (17건)

HLA and Disease Associations in Koreans안스데반, 김태규, 최희백pp. 324-335T Cell Receptor Signaling That Regulates the Development of Intrathymic Natural Regulatory T Cells윤철희, 황수진, 송기덕pp. 336-341Modulation of Glial and Neuronal Migration by Lipocalin-2 in Zebrafish이원하, 김호, 이신려, 박해철, 이명식, 석경호pp. 342-347NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells임종석, 정혜윤, 강경아, 남소림pp. 348-357Influence of Interferon-γ Deficiency in Immune Tolerance Induced by Male Islet Transplantation박정규, 임영경, 김용희pp. 358-363
원문 보기